Cartesian Therapeutics (RNAC) Other Working Capital Changes (2017 - 2024)

Cartesian Therapeutics (RNAC) has 8 years of Other Working Capital Changes data on file, last reported at -$412000.0 in Q2 2024.

• On a quarterly basis, Other Working Capital Changes rose 37.0% year-over-year to -$412000.0 in Q2 2024; TTM through Mar 2025 was -$412000.0, a 95.59% increase from a year earlier, with the FY2024 full-year figure at -$5.8 million, down 211.28% from the prior year.
• Other Working Capital Changes for Q2 2024 stood at -$412000.0, up from -$5.4 million in the prior quarter.
• Over the last five years, Other Working Capital Changes for RNAC reached as high as $5.8 million in Q1 2025 and fell as low as -$2.8 million in Q4 2022.
• Historically, Other Working Capital Changes has averaged $152411.8 across 5 years, with a median of -$70000.0 in 2022.
• On a YoY basis, Other Working Capital Changes climbed as much as 4875700.0% in 2020 and fell as far as 1542.86% in 2020.
• Year by year, Other Working Capital Changes stood at -$5.0 million in 2020, then tumbled by 238.06% to -$17.1 million in 2021, then jumped by 49.26% to -$8.7 million in 2022, then jumped by 73.77% to -$2.3 million in 2023, then surged by 81.87% to -$412000.0 in 2024.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were -$412000.0 in Q2 2024, -$5.4 million in Q1 2024, and -$2.3 million in Q4 2023.